Effect of an intensive nutritional treatment in nutritional status of head and neck cancer patients in stages III and IV [Evaluación del impacto de un tratamiento nutricional intensivo sobre el estado nutricional de pacientes con cáncer de
Por:
Fuchs V., Barbosa V., Mendoza J., Vargas A., Amancio O., Hernández-Cuéllar A., Arana-Rivera E.
Publicada:
1 ene 2008
Resumen:
Objective: Malnutrition and accelerated weight loss are frequent secondary diagnosis in patients with cancer. Head and neck cancer (H & N Cancer) affects nutritional status because of the tumor type and localization. The aim of the study was to assess the effect of an intensive nutritional treatment (INT) on nutritional status of H & N cancer patients, stages III and IV and to compare that with a historical control whose nutritional treatment was conventional (CT). Methods: All patients were nutritionally assessed before oncological treatment started (anthropometrical, biochemical, and dietetically). A nutritional feeding plan according to their nutritional personal need was calculated. In case it was impossible to cover all the nutritional requirements orally, a feeding tube was placed. Nutritional follow up was performed each 21 days, during their oncological treatment in four occasions. The results obtained were compared with those obtained from the patients who received the CT that consisted only in nutritional counseling by the attending physician; the statistical test used was Mann Whitney U test. Results: The INT was associated with maintenance of the nutritional status along their oncological treatment. The statistical significant parameters were: weight 55 to 47 kg in the CT group vs 59 a 58 kg in the INT group (p < 0.0001), and hemoglobin: from 13 to 11 g/dl in the CT group vs 14 to 13 g/dl in the INT group (p < 0.002) as the most important ones. In the rest of the data we can observe a clear tendency of increasing the nutrition parameters in patients the INT group, while in the CT group, they showed a persistent decrease. Conclusion: We concluded that patients who received the INT as part of their oncological treatment deteriorated less their nutritional status than those who received a CT.
Filiaciones:
Fuchs V.:
Servicio de Oncología, Hospital General de México, México, Mexico
Hospital General de México, Servicio de Oncología, Pabellón 111, Dr. Balmis, 148 Col. Doctores, 06726 México DF, Mexico
Barbosa V.:
Servicio de Oncología, Hospital General de México, México, Mexico
Mendoza J.:
Servicio de Oncología, Hospital General de México, México, Mexico
Vargas A.:
Servicio de Oncología, Hospital General de México, México, Mexico
Amancio O.:
Servicio de Oncología, Hospital General de México, México, Mexico
Hernández-Cuéllar A.:
Servicio de Oncología, Hospital General de México, México, Mexico
Arana-Rivera E.:
Servicio de Oncología, Hospital General de México, México, Mexico
|